• Episode: 66 - John Lambert on Antibody Drug Conjugates Then, Now, & Beyond

  • 2024/10/16
  • 再生時間： 40 分
  • ポッドキャスト

Episode: 66 - John Lambert on Antibody Drug Conjugates Then, Now, & Beyond

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • October 15, 2024 | In this month’s episode of The Chain, host Rakesh Dixit, PhD, DABT, president and founder of Bionavigen Oncology and Regio Biosciences, and John Lambert, PhD, consultant, about antibody drug conjugates (ADCs) then, now, and beyond. Lambert shares his experiences from his decades-long career at ImmunoGen, why ADCs are more successful now compared to in the past, and where he sees ADCs going forward. He also discusses his thoughts on the half-life of diffusible payloads, the toxicity of the bystander effect, and more.

    LINKS:
    Bionavigen
    ImmunoGen

    続きを読む 一部表示

あらすじ・解説

October 15, 2024 | In this month’s episode of The Chain, host Rakesh Dixit, PhD, DABT, president and founder of Bionavigen Oncology and Regio Biosciences, and John Lambert, PhD, consultant, about antibody drug conjugates (ADCs) then, now, and beyond. Lambert shares his experiences from his decades-long career at ImmunoGen, why ADCs are more successful now compared to in the past, and where he sees ADCs going forward. He also discusses his thoughts on the half-life of diffusible payloads, the toxicity of the bystander effect, and more.

LINKS:
Bionavigen
ImmunoGen

続きを読む 一部表示

Episode: 66 - John Lambert on Antibody Drug Conjugates Then, Now, & Beyondに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。